Consequences for the management of cytomegalovirus

AIDS, Supplement

Volumn 10, Issue 1, 1996, Pages

  Katlama, Christine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cytomegalovirus; Ganciclovir; Pre emptive therapy; Prophylaxis; Reactivation; Viral load

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR; ZIDOVUDINE;

CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; TISSUE INJURY; VIRUS TITRATION;

ADMINISTRATION, ORAL; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0029804057     PISSN: 13502840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Gallant JE, Moore RD, Richman D, et al.: Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992, 166:1233-1237.
2. Reicher CM, O'Leary TJ, Levens DL, et al.: Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 1993, 112:357-382.
3. Studies of ocular complications of AIDS Research group in collaboration with the AIDS Clinical Trial Group: Mortality of patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992, 326:213-220.
4. Katlama C, Matheron S, Mary-Krause M, et al.: Prevoco: incidence and risk factors for CMV, MAC, cryptosporidiosis and microsporidiosis in late stage HIV disease . XI International Conference on AIDS. Vancouver, July 1996 [abstract Wa.B.3245].
5. Gerard L, Salmon-Ceron D, Pepin JM, et al.: Prevalence of viraemia according to the CD4+ count for CMV prophylaxis in HIV-infected patients . 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, October 1993 [abstract 1064].
6. Drouet E, Michelson S, Denoyel G, Colimon R: Polymerase chain reaction detection of HCMV in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion. J Virol Methods 1993, 45:259-276.
7. Fox JC, Griffith PD, Emery VC: Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 1992, 73:2405-2408.
8. Schafer P, Braun RW, Möhring K, et al.: Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophorese. J Gen Virol 1993, 74: 2699-2707.
9. Zipeto D, Baldani F, Zella D, et al.: Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes in immunocompromised patients by the polymerase chain reaction. J Virol Methods 1993, 44:45-56.
10. Rasmussen L, Morris S, Zipeto D, et al.: Quantification of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus infected patients could predict cytomegalovirus retinitis. J Infect Dis 1995, 171:177-182.
11. Freymuth F, Genetay E, Petitjean J, et al.: Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection. J Clin Microbiol 1994, 32:1604-1608.
12. Spector SA, Merill R, Wolf D, Dankner WM: Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992, 30:2359-2365.
13. Gozlan J, Salord JM, Chouard C, et al.: Human cytomegalovirus (HCMV) late mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J Clin Microbiol 1993, 31:1943-1945.
14. Spector SA, Pilcher M, Lamy M, et al.: PCR of plasma for cytomegalovirus DNA identifies HIV-infected persons most likely to benefit from oral ganciclovir prophylaxis. XI International Conference on AIDS. Vancouver , July 1996 [abstract Th.B.302].
15. Salmon-Ceron D, Gerard L, Houhou N, et al.: CMV viral load: a prognostic factor for CMV disease or death in a phase II trial of foscarnet in HIV patients with CMV viremia. 36th International Conference Antimicrobial Agents Chemotherapy. New Orleans, September 1996 [abstract].